Skip to main content
Private placement pulls in $7M for NeuroMetrix

A private placement of Series F convertible preferred stock has brought in about $7 million in gross proceeds for NeuroMetrix. The proceeds, which will be provided in two tranches, will be used for general working capital purposes, as well as for continuing US commercialization of the Quell over-the-counter wearable pain relief device.

Full Story: